{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T10:57:16Z","timestamp":1753181836104,"version":"3.40.2"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Indian Journal of Medical Microbiology"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.ijmmb.2024.100784","type":"journal-article","created":{"date-parts":[[2024,12,25]],"date-time":"2024-12-25T20:19:49Z","timestamp":1735157989000},"page":"100784","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Audit for antifungal treatment usage in adults with invasive fungal infection: A prospective observational study"],"prefix":"10.1016","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0171-4438","authenticated-orcid":false,"given":"Ankesh","family":"Gupta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Immaculata","family":"Xess","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manish","family":"Soneja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vishakh C","family":"Keri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kapil","family":"Sikka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4703-9733","authenticated-orcid":false,"given":"Vijaydeep","family":"Siddharth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janya","family":"Sachdev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.M.","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arvind","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naveet","family":"Wig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3169-8419","authenticated-orcid":false,"given":"Gagandeep","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijmmb.2024.100784_bib1","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s15010-015-0742-5","article-title":"Hospital use of systemic antifungal drugs: a multi-center surveillance update from Germany","volume":"43","author":"Gross","year":"2015","journal-title":"Infection"},{"key":"10.1016\/j.ijmmb.2024.100784_bib2","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1093\/jac\/dku053","article-title":"Evaluation of antifungal use in a tertiary care institution: antifungal stewardship urgently needed","volume":"69","author":"Valerio","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijmmb.2024.100784_bib3","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.3201\/eid2007.140087","article-title":"Population-based analysis of invasive fungal infections, France, 2001-2010","volume":"20","author":"Bitar","year":"2014","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.ijmmb.2024.100784_bib4","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s00134-014-3603-2","article-title":"Incidence, characteristics and outcome of ICU-acquired candidemia in India","volume":"41","author":"Chakrabarti","year":"2015","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.ijmmb.2024.100784_bib5","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1086\/664909","article-title":"Antimicrobial stewardship at a large tertiary care academic medical center: cost analysis before, during, and after a 7-year program","volume":"33","author":"Standiford","year":"2012","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.ijmmb.2024.100784_bib6","doi-asserted-by":"crossref","first-page":"433","DOI":"10.3324\/haematol.2016.152900","article-title":"ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patients","volume":"102","author":"Tissot","year":"2017","journal-title":"Haematologica"},{"key":"10.1016\/j.ijmmb.2024.100784_bib7","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1086\/649858","article-title":"Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of America","volume":"50","author":"Perfect","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijmmb.2024.100784_bib8","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1086\/649858","article-title":"Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of America","volume":"50","author":"Perfect","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijmmb.2024.100784_bib9","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/civ933","article-title":"Clinical practice guideline for the management of candidiasis: 2016 update by the infectious diseases society of America","volume":"62","author":"Pappas","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijmmb.2024.100784_bib10","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/ciw326","article-title":"Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the infectious diseases society of America","volume":"63","author":"Patterson","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijmmb.2024.100784_bib11","doi-asserted-by":"crossref","first-page":"S121","DOI":"10.1093\/cid\/ciaa1751","article-title":"EORTC\/MSGERC definitions of invasive fungal diseases: summary of activities of the intensive care unit working group","volume":"72","author":"Bassetti","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijmmb.2024.100784_bib12","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1086\/588660","volume":"46","author":"De Pauw","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijmmb.2024.100784_bib13","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/j.1469-0691.2012.03891.x","article-title":"A non-compulsory stewardship programme for the management of antifungals in a university-affiliated hospital","volume":"19","author":"L\u00f3pez-Medrano","year":"2013","journal-title":"Clin Microbiol Infection"},{"key":"10.1016\/j.ijmmb.2024.100784_bib14","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1093\/jac\/37.1.175","article-title":"An audit of the use of antifungal agents","volume":"37","author":"Guti\u00e9rrez","year":"1996","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijmmb.2024.100784_bib15","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1086\/587633","article-title":"Inappropriate use of antifungal medications in a tertiary care center in Thailand: a prospective study","volume":"29","author":"Sutepvarnon","year":"2008","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.ijmmb.2024.100784_bib16","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1080\/1120009X.2018.1507086","article-title":"Impact of infectious diseases consultation as a part of an antifungal stewardship programme on candidemia outcome in an Italian tertiary-care","volume":"30","author":"Menichetti","year":"2018","journal-title":"University hospital. Journal of Chemotherapy"},{"key":"10.1016\/j.ijmmb.2024.100784_bib17","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1002\/pds.3278","article-title":"Use of systemic antifungals in daily clinical practice in the haematology and oncology setting: results of a prospective observational analysis","volume":"21","author":"Metzke","year":"2012","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.ijmmb.2024.100784_bib18","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1038\/bmt.2009.325","article-title":"Drug interactions and adverse events associated with antimycotic drugs used for invasive aspergillosis in hematopoietic SCT","volume":"45","author":"Egger","year":"2010","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.ijmmb.2024.100784_bib19","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1002\/jcph.772","article-title":"Adverse drug reactions in patients receiving systemic antifungal therapy at a high-complexity hospital","volume":"56","author":"de Souza","year":"2016","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.ijmmb.2024.100784_bib20","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1111\/imj.12600","article-title":"Consensus guidelines for optimising antifungal drug delivery and monitoring to avoid toxicity and improve outcomes in patients with haematological malignancy, 2014","volume":"44","author":"Chau","year":"2014","journal-title":"Intern Med J"},{"key":"10.1016\/j.ijmmb.2024.100784_bib21","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1111\/bcp.13521","article-title":"Adverse effects of amphotericin B in children; a retrospective comparison of conventional and liposomal formulations","volume":"84","author":"Andrew","year":"2018","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.ijmmb.2024.100784_bib22","doi-asserted-by":"crossref","first-page":"26","DOI":"10.5863\/1551-6776-26.1.26","article-title":"Characterization of therapeutic drug monitoring practices of voriconazole and Posaconazole at a pediatric hospital","volume":"26","author":"Duehlmeyer","year":"2021","journal-title":"J Pediatr Pharmacol Therapeut"},{"key":"10.1016\/j.ijmmb.2024.100784_bib23","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1086\/367933","article-title":"Voriconazole: a new triazole antifungal agent","volume":"36","author":"Johnson","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijmmb.2024.100784_bib24","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1111\/ctr.12834","article-title":"Adverse effects of voriconazole: over a decade of use","volume":"30","author":"Levine","year":"2016","journal-title":"Clin Transplant"},{"key":"10.1016\/j.ijmmb.2024.100784_bib25","doi-asserted-by":"crossref","first-page":"3455","DOI":"10.1128\/AAC.00579-07","article-title":"Induction of voriconazole metabolism by rifampin in a patient with acute myeloid leukemia: importance of interdisciplinary communication to prevent treatment errors with complex medications","volume":"51","author":"Geist","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijmmb.2024.100784_bib26","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s11096-012-9712-5","article-title":"A matched-control evaluation of an antifungal bundle in the intensive care unit at a university teaching hospital","volume":"35","author":"Guarascio","year":"2013","journal-title":"Int J Clin Pharm"}],"container-title":["Indian Journal of Medical Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0255085724002597?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0255085724002597?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,23]],"date-time":"2025-03-23T19:12:53Z","timestamp":1742757173000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0255085724002597"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":26,"alternative-id":["S0255085724002597"],"URL":"https:\/\/doi.org\/10.1016\/j.ijmmb.2024.100784","relation":{},"ISSN":["0255-0857"],"issn-type":[{"type":"print","value":"0255-0857"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Audit for antifungal treatment usage in adults with invasive fungal infection: A prospective observational study","name":"articletitle","label":"Article Title"},{"value":"Indian Journal of Medical Microbiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijmmb.2024.100784","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":". 2024 Indian Association of Medical Microbiologists. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"100784"}}